170.54

1.41% 2.37

Agilent Technologies Inc (A)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Agilent Technologies Inc stock is traded at $170.54, with a volume of 1.54M. It is up +1.41% in the last 24 hours and up +16.07% over the past month. Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Previous Close:

$168.17

Open:

$168.57

24h Volume:

1.54M

Relative Volume:

0.69

Market Cap:

$48.08B

Revenue:

$7.23B

Net Income/Loss:

$1.41B

P/E Ratio:

34.25

EPS:

4.979

Net Cash Flow:

$1.09B

1W Performance:

-0.44%

1M Performance:

+16.07%

6M Performance:

+48.22%

1Y Performance:

+24.83%

1-Day Range:

$0.00

1-Week Range:

$163.32

$176.38

52-Week Range:

$108.35

$177.05

Agilent Technologies Inc Stock (A) Company Profile

Name

Agilent Technologies Inc

Sector

Healthcare (1050)

Industry

Diagnostics & Research (44)

Phone

(408) 345-8886

Address

5301 STEVENS CREEK BLVD, SANTA CLARA, CA

Employee

18,100

Twitter

@agilent

Next Earnings Date

2026-11-23

Latest SEC Filings

A's Discussions on Twitter

Compare A vs TMO, DHR, NTRA, IQV

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
A Agilent Technologies Inc	170.54	48.08B	7.23B	1.41B	1.09B	4.979
TMO Thermo Fisher Scientific Inc	658.02	243.30B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	219.81	154.52B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	400.71	57.76B	2.50B	-226.32M	71.51M	-1.6412
IQV Iqvia Holdings Inc	259.88	42.78B	16.63B	1.39B	2.12B	8.0674

Agilent Technologies Inc Stock (A) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-09-26	Resumed	UBS	Neutral
Jul-09-26	Resumed	Jefferies	Hold
Jun-26-26	Resumed	Bernstein	Outperform
Jun-11-26	Initiated	Piper Sandler	Neutral
May-28-26	Upgrade	BofA Securities	Neutral → Buy
May-27-26	Initiated	RBC Capital Mkts	Outperform
Jan-20-26	Initiated	HSBC Securities	Buy
Jan-05-26	Upgrade	Evercore ISI	In-line → Outperform
Dec-15-25	Upgrade	Barclays	Equal Weight → Overweight
Dec-09-25	Initiated	Goldman	Buy
Dec-02-25	Initiated	Morgan Stanley	Overweight
Oct-08-25	Initiated	Rothschild & Co Redburn	Buy
Oct-08-25	Upgrade	UBS	Neutral → Buy
Feb-10-25	Upgrade	Barclays	Underweight → Equal Weight
Aug-28-24	Initiated	Wells Fargo	Overweight
Jul-10-24	Upgrade	Citigroup	Neutral → Buy
Jun-27-24	Downgrade	Wolfe Research	Outperform → Peer Perform
Jun-03-24	Resumed	Jefferies	Hold
Apr-05-24	Upgrade	Stifel	Hold → Buy
Dec-13-23	Initiated	Wolfe Research	Outperform
Dec-12-23	Downgrade	BofA Securities	Buy → Neutral
Nov-17-23	Downgrade	UBS	Buy → Neutral
Sep-28-23	Initiated	Bernstein	Mkt Perform
Jul-31-23	Downgrade	Evercore ISI	Outperform → In-line
May-24-23	Reiterated	Barclays	Equal Weight
May-24-23	Reiterated	BofA Securities	Buy
May-24-23	Reiterated	Citigroup	Neutral
May-24-23	Reiterated	Credit Suisse	Outperform
May-24-23	Reiterated	Evercore ISI	Outperform
May-24-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-24-23	Reiterated	Robert W. Baird	Outperform
May-24-23	Reiterated	SVB Securities	Outperform
May-24-23	Reiterated	Stifel	Hold
May-24-23	Reiterated	TD Cowen	Outperform
May-24-23	Reiterated	Wells Fargo	Overweight
May-11-23	Initiated	Barclays	Equal Weight
Jan-10-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Aug-25-22	Initiated	Credit Suisse	Outperform
Jul-20-22	Initiated	UBS	Buy
Jul-08-22	Downgrade	Citigroup	Buy → Neutral
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Feb-23-22	Reiterated	BofA Securities	Buy
Feb-23-22	Reiterated	Citigroup	Buy
Feb-23-22	Reiterated	Cowen	Outperform
Feb-23-22	Reiterated	Evercore ISI	Outperform
Feb-23-22	Reiterated	Stifel	Hold
Feb-23-22	Reiterated	Wells Fargo	Overweight
Nov-23-21	Reiterated	BofA Securities	Buy
Nov-23-21	Reiterated	Cowen	Outperform
Nov-23-21	Reiterated	Stifel	Hold
Mar-18-21	Upgrade	Citigroup	Neutral → Buy
Feb-17-21	Upgrade	BofA Securities	Neutral → Buy
Dec-02-20	Initiated	Goldman	Buy
Nov-25-20	Upgrade	UBS	Neutral → Buy
Nov-17-20	Upgrade	Cleveland Research	Neutral → Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Sep-30-20	Initiated	Atlantic Equities	Neutral
Aug-19-20	Reiterated	BofA Securities	Neutral
Aug-19-20	Reiterated	Citigroup	Neutral
Aug-19-20	Reiterated	Jefferies	Buy
Aug-19-20	Reiterated	Robert W. Baird	Outperform
Aug-19-20	Reiterated	SVB Leerink	Outperform
Aug-19-20	Reiterated	Stifel	Hold
Aug-19-20	Reiterated	Wells Fargo	Overweight
Feb-24-20	Downgrade	Needham	Buy → Hold
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Neutral
Nov-26-19	Reiterated	Needham	Buy
Nov-15-19	Initiated	Stifel	Hold
Oct-18-19	Downgrade	UBS	Buy → Neutral
Jul-16-19	Downgrade	BofA/Merrill	Buy → Neutral
Jul-15-19	Downgrade	Barclays	Overweight → Equal Weight

View All

Agilent Technologies Inc Stock (A) Latest News

Oct 09, 2026

Should You Invest in the First Trust Water ETF (FIW)? - Zacks Investment Research

Oct 09, 2026

Oct 06, 2026

Barclays Adjusts Price Target on Agilent Technologies to $195 From $175, Keeps Overweight Rating - marketscreener.com

Oct 06, 2026

Oct 05, 2026

Agilent Expands Oligonucleotide Manufacturing Capabilities With New Boulder Lab - CHEManager

Oct 05, 2026

Agilent Technologies Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

Oct 05, 2026

Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.

Oct 05, 2026

Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion Opportunity - GlobeNewswire Inc.

Oct 05, 2026

Magnetic Beads MarketGlobal Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion - GlobeNewswire Inc.

Oct 05, 2026

Oct 04, 2026

Agilent Technologies To Go Ex-Dividend On October 6th, 2026 With 0.255 USD Dividend Per Share - Moomoo

Oct 04, 2026

A6533886 Bond Yield and Price — FINRA:A6533886 - TradingView

Oct 04, 2026

Oct 02, 2026

AIgnite Execution And Long Replacement Cycles Will Support This Fairly Valued Bullish Case - Simply Wall Street

Oct 02, 2026

Oct 01, 2026

A5886204 Bond Profile: Coupon and Redemption - TradingView

Oct 01, 2026